![Mathias Hothum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathias Hothum
Director/Board Member at
IMMATICS N.V.
Net worth: 4 M $ as of 30/05/2026
Profile
Dr. Mathias Hothum is a Chairman-Supervisory Board at GEUDER AG, a Co-Managing Director at TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG, a Managing Director at dievini Hopp BioTech holding GmbH & Co. KG, a Managing Director at dievini Verwaltungs GmbH, a Managing Director at Hmm Consulting and a Managing Director at OH Venture Management GmbH.
He is on the Board of Directors at Immatics NV, CureVac NV, Heidelberg Pharma AG, Apogenix AG, CureVac SE, Molecular Health GmbH and Novaliq GmbH.
Dr. Hothum was previously employed as a Co-Managing Director by Drug Delivery Systems Beteiligungs GmbH, a Non-Executive Director by AC Immune SA, a Chairman by Joimax GmbH, and a Member-Supervisory Board by Molecular Health, Inc. He also served on the board at Weinheim 216 GmbH & Co. KG.
He received his undergraduate degree from the University of Mannheim and a doctorate degree from Otto-von-Guericke-Universität Magdeburg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMATICS N.V. 0.25% | 16/03/2026 | 329,521 ( 0.25% ) | 4 M $ | 30/05/2026 |
Mathias Hothum active positions
| Companies | Position | Start |
|---|---|---|
| HEIDELBERG PHARMA AG | Director/Board Member | 29/07/2015 |
| CUREVAC | Director/Board Member | 31/07/2015 |
| IMMATICS N.V. | Director/Board Member | 19/06/2023 |
GEUDER AG
 GEUDER AG Medical SpecialtiesHealth Technology Manufactures ophthalmologic surgical instruments and devices | Chairman | - |
Molecular Health GmbH
 Molecular Health GmbH Packaged SoftwareTechnology Services Provides data-driven software technology solutions for transforming biomedical data into actionable insights | Director/Board Member | - |
Hmm Consulting | Chief Executive Officer | - |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
 TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance Provides real estate services | Chief Executive Officer | - |
dievini Verwaltungs GmbH | Chief Executive Officer | - |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech hldg invests in companies located in Germany. The firm focuses on the biotechnology sectors and industries. It provides financing for early stage capital requirements. | Chief Executive Officer | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Mathias Hothum
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Mathias Hothum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
University of Mannheim
 University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases | Health Technology |
Otto-von-Guericke-Universität Magdeburg
 Otto-von-Guericke-Universität Magdeburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
dievini Hopp BioTech holding GmbH & Co. KG
dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech hldg invests in companies located in Germany. The firm focuses on the biotechnology sectors and industries. It provides financing for early stage capital requirements. | Finance |
GEUDER AG
GEUDER AG Medical SpecialtiesHealth Technology Manufactures ophthalmologic surgical instruments and devices | Health Technology |
Weinheim 216 GmbH & Co. KG
 Weinheim 216 GmbH & Co. KG BiotechnologyHealth Technology Engage in biological research | Health Technology |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Develops and markets systems for endoscopic minimally invasive spinal surgery | Health Technology |
dievini Verwaltungs GmbH | |
Molecular Health GmbH
Molecular Health GmbH Packaged SoftwareTechnology Services Provides data-driven software technology solutions for transforming biomedical data into actionable insights | Technology Services |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions | Technology Services |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Develops and markets drug delivery systems | Health Technology |
Drug Delivery Systems Beteiligungs GmbH
 Drug Delivery Systems Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Finance |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance Provides real estate services | Finance |
OH Venture Management GmbH
 OH Venture Management GmbH Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Hmm Consulting | |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
- Stock Market
- Insiders
- Mathias Hothum
